H.A. Abella
The patient was a married engineer and
father of three. He presented to the emergency room with a global arterial
circulation deficit, aphasia, and hemiplegia. An earlier noncontrast CT of
the brain had found no signs of hemorrhage. An MR scan revealed a
considerable perfusion defect caused by a carotid artery occlusion. He
arrived 1.5 hours too late, however, for intravenous tissue plasminogen
activator thrombolytic therapy.
“What am I going to do?” said Dr. Howard
A. Rowley, chief of neuroradiology at the University of Wisconsin in
Madison. “Say ‘Sorry, I can't do anything more, we are
going to give you an aspirin and send you to rehab?’ I don't
think so.”
Though anecdotal, the account reflects a situation
seen daily at both small hospitals and large stroke care centers across the
U.S. About 750,000 stroke cases will be diagnosed this year, according to
the National Stroke Association. The condition has become a leading cause
of death and disability in the U.S. and Europe. But even though intravenous
tPA was approved more than a decade ago, only about 4% of patients actually
get the drug—mostly those who can make it to the ER within three
hours of stroke onset.
“We are not doing very well with this
disease,” Rowley said. “Maybe it's time to think outside
the box.”
A growing number of recently published studies may be
persuading researchers and clinicians about the possibility of identifying
salvageable brain tissue beyond the established three-hour window for lytic
therapy. Rowley referred to the anecdotal case described above to
illustrate this point. His institution's 15-minute MR scanning
protocol found a perfusion/diffusion mismatch in the engineer's brain
that helped guide further management. The patient underwent intra-arterial
therapy and returned home the next day with no neurological deficit.
“It would have been immoral and unethical not to
treat this patient, or at least offer him this treatment option. Was that
the right thing to do? I don't know, but it was certainly sensible
based on what we knew about him and what we knew about opening vessels as
late as six hours after occlusion,” Rowley said.
Not everyone agrees with this assessment.